Literature DB >> 26043690

Tetramethylpyrazine inhibits neutrophil activation following permanent cerebral ischemia in rats.

Cheng-Yi Chang1, Tsung-Kuei Kao2, Wen-Ying Chen3, Yen-Chuan Ou4, Jian-Ri Li5, Su-Lan Liao6, Shue-Ling Raung6, Chun-Jung Chen7.   

Abstract

Experimental studies have demonstrated the beneficial effects of tetramethylpyrazine (TMP) against ischemic stroke and highlighted its crucial role in anti-inflammatory activity. This study provides evidence of an alternative target for TMP and sheds light on the mechanism of its anti-inflammatory action against ischemic brain injury. We report a global inhibitory effect of TMP on inflammatory cell intracerebral activation and infiltration in a rat model of permanent cerebral ischemia. The results of immunohistochemistry, enzymatic assay, flow cytometric analysis, and cytological analysis revealed that intraperitoneal TMP administration reduced neuronal loss, macrophage/microglia activation, brain parenchyma infiltrative neutrophils, and circulating neutrophils after cerebral ischemia. Biochemical studies of cultured neutrophils further demonstrated that TMP attenuated neutrophil migration, endothelium adhesion, spontaneous nitric oxide (NO) production, and stimuli-activated NO production after cerebral ischemia. In parallel with these anti-neutrophil phenomena, TMP also attenuated the activities of ischemia-induced inflammation-associated signaling molecules, including plasma high-mobility group box-1 protein (HMGB1) and neutrophil toll-like receptor-4 (TLR4), Akt, extracellular signal-regulated kinase (ERK), and inducible nitric oxide synthase. Another finding in this study was that the anti-neutrophil effect of TMP was accompanied by a further elevated expression of NF-E2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) in neutrophils after cerebral ischemia. Taken together, our results suggest that both the promotion of endogenous anti-inflammatory defense capacity and the attenuation of pro-inflammatory responses via targeting of circulating neutrophils by elevating Nrf2/HO-1 expression and inhibiting HMGB1/TLR4, Akt, and ERK signaling might actively contribute to TMP-mediated neuroprotection against cerebral ischemia.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Neutrophils; Stroke; Tetramethylpyrazine

Mesh:

Substances:

Year:  2015        PMID: 26043690     DOI: 10.1016/j.bbrc.2015.05.088

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

1.  The Synergic Effect of Tetramethylpyrazine Phosphate and Borneol for Protecting Against Ischemia Injury in Cortex and Hippocampus Regions by Modulating Apoptosis and Autophagy.

Authors:  Bin Yu; Ming Ruan; Tao Liang; Shi-Wen Huang; Yun Yu; Hai-Bo Cheng; Xiang-Chun Shen
Journal:  J Mol Neurosci       Date:  2017-08-04       Impact factor: 3.444

2.  Tetramethylpyrazine Inhibits Platelet Adhesion and Inflammatory Response in Vascular Endothelial Cells by Inhibiting P38 MAPK and NF-κB Signaling Pathways.

Authors:  Han Zhang; Weiwei Tang; Shuang Wang; Junhua Zhang; Xiang Fan
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

3.  Tetramethylpyrazine Protects Against Oxygen-Glucose Deprivation-Induced Brain Microvascular Endothelial Cells Injury via Rho/Rho-kinase Signaling Pathway.

Authors:  Guang Yang; Chen Qian; Ning Wang; Chenyu Lin; Yan Wang; Guangyun Wang; Xinxin Piao
Journal:  Cell Mol Neurobiol       Date:  2016-07-05       Impact factor: 5.046

Review 4.  Cerebral ischemia in the developing brain.

Authors:  Robert M Dietz; Andra L Dingman; Paco S Herson
Journal:  J Cereb Blood Flow Metab       Date:  2022-06-29       Impact factor: 6.960

5.  Tetramethylpyrazine phosphate and borneol combination therapy synergistically attenuated ischemia-reperfusion injury of the hypothalamus and striatum via regulation of apoptosis and autophagy in a rat model.

Authors:  Bin Yu; Ming Ruan; Tao Liang; Shi-Wen Huang; Sheng-Jin Liu; Hai-Bo Cheng; Xiang-Chun Shen
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 6.  Nrf2-a Promising Therapeutic Target for Defensing Against Oxidative Stress in Stroke.

Authors:  Rongrong Zhang; Mengxue Xu; Yu Wang; Fei Xie; Gang Zhang; Xinyue Qin
Journal:  Mol Neurobiol       Date:  2016-09-30       Impact factor: 5.590

7.  Ligustrazine reverts anthracycline chemotherapy resistance of human breast cancer by inhibiting JAK2/STAT3 signaling and decreasing fibrinogen gamma chain (FGG) expression.

Authors:  Yu-Lin Liu; Ze-Xuan Yan; Yu Xia; Xiao-Ye Xie; Kai Zhou; Li-Li Xu; Yan-Long Shi; Qiang Wang; Jing-Wang Bi
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

8.  Tetramethylpyrazine reduces blood-brain barrier permeability associated with enhancement of peripheral cholinergic anti-inflammatory effects for treating traumatic brain injury.

Authors:  Aimin Wang; Guangbin Zhu; Ping Qian; Tao Zhu
Journal:  Exp Ther Med       Date:  2017-07-10       Impact factor: 2.447

9.  Tetramethylpyrazine Ameliorates Rotenone-Induced Parkinson's Disease in Rats: Involvement of Its Anti-Inflammatory and Anti-Apoptotic Actions.

Authors:  Haidy E Michel; Mariane G Tadros; Ahmed Esmat; Amani E Khalifa; Ahmed M Abdel-Tawab
Journal:  Mol Neurobiol       Date:  2016-08-11       Impact factor: 5.590

Review 10.  Anti-Inflammatory Effects of Traditional Chinese Medicines against Ischemic Injury in In Vivo Models of Cerebral Ischemia.

Authors:  Chin-Yi Cheng; Yu-Chen Lee
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-15       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.